The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 26, 2019
Filed:
Jan. 22, 2016
Applicant:
Palobiofarma, S.l., Mataro, Barcelona, ES;
Inventors:
Julio Castro-Palomino Lária, Barcelona, ES;
Juan Camacho Gómez, Barcelona, ES;
Assignee:
PALOBIOFARMA, S.L., Mataro, Barcelona, ES;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 277/32 (2006.01); C07D 277/38 (2006.01); A61K 31/426 (2006.01); A61K 31/427 (2006.01); C07D 233/56 (2006.01); C07D 417/12 (2006.01); C07D 417/14 (2006.01); A61P 27/06 (2006.01); A61P 11/06 (2006.01); A61P 19/02 (2006.01); A61P 13/12 (2006.01); A61P 35/00 (2006.01); A61K 31/454 (2006.01); A61K 31/167 (2006.01); A61K 31/277 (2006.01); A61K 31/352 (2006.01); A61K 31/47 (2006.01); A61K 31/519 (2006.01); A61K 31/549 (2006.01);
U.S. Cl.
CPC ...
A61K 31/426 (2013.01); A61K 31/427 (2013.01); A61K 31/454 (2013.01); A61P 11/06 (2018.01); A61P 13/12 (2018.01); A61P 19/02 (2018.01); A61P 27/06 (2018.01); A61P 35/00 (2018.01); C07D 233/56 (2013.01); C07D 417/12 (2013.01); C07D 417/14 (2013.01); A61K 31/167 (2013.01); A61K 31/277 (2013.01); A61K 31/352 (2013.01); A61K 31/47 (2013.01); A61K 31/519 (2013.01); A61K 31/549 (2013.01); A61K 2300/00 (2013.01);
Abstract
Modulators of adenosin Areceptors of formula (I): And procedure for preparing these compounds. Other objectives of the present invention are to provide pharmaceutical compositions comprising an effective amount of these compounds and the use of the compounds for manufacturing a medicament for the treatment of pathological conditions or diseases that can improve by modulation of the adenosine Areceptor.